Random Forest AI Model Superior for Inpatient Mortality Prognostication in Cirrhosis

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 24, 2025.

via HealthDay

THURSDAY, July 24, 2025 -- For inpatients with cirrhosis, a machine learning (ML) model using random forest (RF) analysis is superior for prediction of inpatient mortality, according to a study published online July 23 in Gastroenterology.

Scott Silvey, from Virginia Commonwealth University in Richmond, and colleagues used ML approaches to enhance the prognostication of inpatient mortality in a cohort that enrolled inpatients with cirrhosis globally. Admission-day data were used to predict inpatient mortality. The prospective CLEARED cohort included 7,239 inpatients with cirrhosis from 115 centers: 22.5, 41, and 34 percent belonged to low-/low-middle-income countries (L-LMIC), upper-middle income countries (UMIC), and high-income countries (HIC), respectively.

Overall, 11.1 percent of patients died in the hospital. The researchers found the best area under the curve (AUC) with RF (0.815), with high calibration, which was significantly better than parametric logistic regression and LASSO models (AUCs, 0.774 and 0.787, respectively). RF remained better than logistic regression regardless of country income level (AUC, 0.806, 0.867, and 0.768 for HIC, UMIC, and L-LMIC, respectively). External validation was conducted in a cohort of 28,670 veterans, which had 4 percent inpatient mortality. Using the CLEARED-derived RF model, the AUC was 0.859.

"This machine learning model that has an equitable global representation could be beneficial in rapid prognostication of patients hospitalized with cirrhosis," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-25 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords